C

Cyllene Therapeutics

Latest funding round: 36 M$

C

• City : Paris
• Round : Série C
• Sector : Health

Cyllene Therapeutics develops DNA medicines and a gene therapy platform targeting neurological disorders among other conditions. Its treatments target patients with severe chronic diseases that are insufficiently treated.